VITAS
搜索文档
Chemed reiterates $22–$22.30 EPS guidance for 2025 as Roto-Rooter margins stabilize and VITAS targets Medicare Cap resolution (NYSE:CHE)
Seeking Alpha· 2025-10-30 01:07
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
